142 related articles for article (PubMed ID: 20092724)
61. Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.
Rausei S; Lianos GD; Proserpio I; Ruspi L; Galli F; Frattini F; Mangano A; Rovera F; Boni L; Roukos DH; Pinotti G; Dionigi G
Tumori; 2015; 101(5):511-6. PubMed ID: 25908036
[TBL] [Abstract][Full Text] [Related]
62. [A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer].
Qu JJ; Shi YR; Liu FR; Ma SQ; Ma FY
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):664-7. PubMed ID: 20878572
[TBL] [Abstract][Full Text] [Related]
63. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.
Velut G; Mary F; Wind P; Aparicio T
Dig Liver Dis; 2014 Dec; 46(12):1135-6. PubMed ID: 25179158
[No Abstract] [Full Text] [Related]
64. Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.
Han DS; Suh YS; Kong SH; Lee HJ; Im SA; Bang YJ; Kim WH; Yang HK
J Surg Oncol; 2013 Apr; 107(5):511-6. PubMed ID: 23090791
[TBL] [Abstract][Full Text] [Related]
65. [Oxaliplatin in combination with calcium folinate and fluorouracil as neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Fang Y; Wang YJ; Li F; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):510-2. PubMed ID: 17143797
[TBL] [Abstract][Full Text] [Related]
66. Effects of preoperative chemotherapy on gastric adenocarcinomas. A morphologic study of 25 cases.
Kiyabu M; Leichman L; Chandrasoma P
Cancer; 1992 Nov; 70(9):2239-45. PubMed ID: 1327491
[TBL] [Abstract][Full Text] [Related]
67. Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
Mary F; Zaanan A; Boige V; Artru P; Samalin E; Coriat R; Bachet JB; Boubaya M; Benallaoua M; Tougeron D; Afchain P; Locher C; Baumgaertner I; Lecaille C; des Guetz G; Aparicio T;
Dig Liver Dis; 2016 Dec; 48(12):1498-1502. PubMed ID: 27623185
[TBL] [Abstract][Full Text] [Related]
68. [Application study on regional infusion chemotherapy by celiac trunk during operation in advanced gastric cancer patients].
You X; Qian H; Qin L; Wang Y; Li W; Lian Y; Zhao X; Xu N; Huang C; Chen Z; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1044-1048. PubMed ID: 27680076
[TBL] [Abstract][Full Text] [Related]
69. Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer.
Barzi A; Choi A; Tsao-Wei D; Iqbal S; El-Khoueiry A; Agafitei DR; Cologne KG; Lenz HJ
Oncologist; 2020 Dec; 25(12):e1879-e1885. PubMed ID: 32649004
[TBL] [Abstract][Full Text] [Related]
70. [Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer].
Li T; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):104-6. PubMed ID: 21365500
[TBL] [Abstract][Full Text] [Related]
71. Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?
Misra S; Pedroso FE; DiPasco PJ; Solomon NL; Gennis E; Franceschi D; Ardalan B; Koniaris LG
J Surg Res; 2012 Dec; 178(2):623-31. PubMed ID: 22682528
[TBL] [Abstract][Full Text] [Related]
72. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.
Mutze K; Langer R; Becker K; Ott K; Novotny A; Luber B; Hapfelmeier A; Göttlicher M; Höfler H; Keller G
Ann Surg Oncol; 2010 Dec; 17(12):3336-43. PubMed ID: 20585871
[TBL] [Abstract][Full Text] [Related]
73. Tolerance and efficacy of adjuvant chemoradiotherapy with FOLFIRI in adenocarcinoma of stomach and GI junction.
Des Guetz G; Bouillet T; Wind P; Morere JF
Gastroenterol Clin Biol; 2008 Oct; 32(10):875-6. PubMed ID: 18487031
[No Abstract] [Full Text] [Related]
74. FOLFOX as Perioperative Chemotherapy of localized Gastric Cancer: Efficacy and Tolerance.
Tanz R; El Mhadi C; Toreis M; Khmamouch MR; Mahfoud T; Ali AA; Errihani H; Ichou M
Gulf J Oncolog; 2016 May; 1(21):17-20. PubMed ID: 27250883
[TBL] [Abstract][Full Text] [Related]
75. Interleukin-10 and -12 predict chemotherapy-associated toxicity in esophageal adenocarcinoma.
Schauer MC; Holzmann B; Peiper M; Friess H; Knoefel WT; Theisen J
J Thorac Oncol; 2010 Nov; 5(11):1849-54. PubMed ID: 20881642
[TBL] [Abstract][Full Text] [Related]
76. Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy.
Guo T; Yao F; Yang AM; Li XY; Zhong DR; Wu DS; Wu X; Lu XH
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e28-32. PubMed ID: 23279745
[TBL] [Abstract][Full Text] [Related]
77. Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery.
Bringeland EA; Wasmuth HH; Fougner R; Mjønes P; Grønbech JE
Br J Surg; 2014 Dec; 101(13):1712-20. PubMed ID: 25312592
[TBL] [Abstract][Full Text] [Related]
78. A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.
Wang X; Zhao L; Liu H; Zhong D; Liu W; Shan G; Dong F; Gao W; Bai C; Li X
Br J Cancer; 2016 Jun; 114(12):1326-33. PubMed ID: 27172250
[TBL] [Abstract][Full Text] [Related]
79. [Efficacies of neoadjuvant chemotherapy plus nutritional support in advanced gastric cancer complicated with pylori obstruction].
Sun Y; Xu X; Hu J; Xu J; Qian Z; Qian X; Zhang Q; Shao Q; Ye Z
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):584-6. PubMed ID: 24762686
[TBL] [Abstract][Full Text] [Related]
80. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
Neofytou K; Giakoustidis A; Smyth EC; Cunningham D; Mudan S
J Surg Oncol; 2015 May; 111(6):768-70. PubMed ID: 25556724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
